KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $84.6 million.

  • Pacific Biosciences Of California's Change in Acquisitions & Divestments fell 3429.36% to $84.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.6 million, marking a year-over-year decrease of 3638.03%. This contributed to the annual value of $594.0 million for FY2024, which is 2281.29% down from last year.
  • As of Q3 2025, Pacific Biosciences Of California's Change in Acquisitions & Divestments stood at $84.6 million, which was down 3429.36% from $82.0 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Change in Acquisitions & Divestments peaked at $320.1 million during Q3 2023, and registered a low of $68.4 million during Q1 2021.
  • In the last 5 years, Pacific Biosciences Of California's Change in Acquisitions & Divestments had a median value of $124.9 million in 2022 and averaged $139.0 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 41213.37% in 2021, then crashed by 5976.03% in 2024.
  • Over the past 5 years, Pacific Biosciences Of California's Change in Acquisitions & Divestments (Quarter) stood at $199.2 million in 2021, then rose by 10.62% to $220.4 million in 2022, then plummeted by 37.26% to $138.3 million in 2023, then decreased by 17.89% to $113.5 million in 2024, then dropped by 25.45% to $84.6 million in 2025.
  • Its Change in Acquisitions & Divestments was $84.6 million in Q3 2025, compared to $82.0 million in Q2 2025 and $113.4 million in Q1 2025.